Search results
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks· 2 days agoFree Report) announced positive new results from an ongoing phase I/II study on pipeline candidate REGN7075. The phase I/II first-in-human, open-label study is evaluating REGN7075, in combination ...